IRWD Ironwood Pharmaceuticals Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: IRWD

Price (delayed)

$10.81

Market cap

$1.68B

P/E Ratio

9.16

Dividend/share

N/A

EPS

$1.18

Enterprise value

$1.35B

Ironwood Pharmaceuticals is a GI-focused healthcare company dedicated to creating medicines that make a difference for patients living with GI diseases. The company discovered, developed and are commercializing linaclotide, the ...

Highlights
The company's equity rose by 37% YoY and by 8% QoQ
IRWD's debt is down by 23% year-on-year
The net income has plunged by 65% YoY but it has grown by 3.9% from the previous quarter
The EPS has dropped by 64% year-on-year but it has increased by 4.4% since the previous quarter
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: http://www.ironwoodpharma.com
Peers: NKTR CPIX

Key stats

What are the main financial stats of IRWD
Market
Shares outstanding
155.35M
Market cap
$1.68B
Enterprise value
$1.35B
Valuations
Price to earnings (P/E)
9.16
Price to book (P/B)
2.36
Price to sales (P/S)
4
EV/EBIT
5.04
EV/EBITDA
5.01
EV/Sales
3.24
Earnings
Revenue
$417.13M
EBIT
$268.6M
EBITDA
$269.95M
Free cash flow
$289.67M
Per share
EPS
$1.18
Free cash flow per share
$1.88
Book value per share
$4.59
Revenue per share
$2.7
TBVPS
$7.48
Balance sheet
Total assets
$1.16B
Total liabilities
$448.43M
Debt
$415.84M
Equity
$706.85M
Working capital
$842.53M
Liquidity
Debt to equity
0.59
Current ratio
36.34
Quick ratio
35.96
Net debt/EBITDA
-1.21
Margins
EBITDA margin
64.7%
Gross margin
100%
Net margin
43.6%
Operating margin
60.6%
Efficiency
Return on assets
17%
Return on equity
29.3%
Return on invested capital
32%
Return on capital employed
23.7%
Return on sales
64.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

IRWD stock price

How has the Ironwood Pharmaceuticals stock price performed over time
Intraday
0.75%
1 week
3.25%
1 month
3.74%
1 year
-3.4%
YTD
-12.75%
QTD
2.76%

Financial performance

How have Ironwood Pharmaceuticals's revenue and profit performed over time
Revenue
$417.13M
Gross profit
$417.13M
Operating income
$252.59M
Net income
$181.98M
Gross margin
100%
Net margin
43.6%
IRWD's net margin has dropped by 65% year-on-year but it is up by 2.3% since the previous quarter
The net income has plunged by 65% YoY but it has grown by 3.9% from the previous quarter
IRWD's operating margin is up by 4.7% year-on-year
The operating income has increased by 3.2% YoY

Growth

What is Ironwood Pharmaceuticals's growth rate over time

Valuation

What is Ironwood Pharmaceuticals stock price valuation
P/E
9.16
P/B
2.36
P/S
4
EV/EBIT
5.04
EV/EBITDA
5.01
EV/Sales
3.24
The EPS has dropped by 64% year-on-year but it has increased by 4.4% since the previous quarter
IRWD's P/E is 9% below its last 4 quarters average of 10.1
The company's equity rose by 37% YoY and by 8% QoQ
IRWD's price to book (P/B) is 16% lower than its last 4 quarters average of 2.8
IRWD's P/S is 18% below its 5-year quarterly average of 4.9 and 2.4% below its last 4 quarters average of 4.1

Efficiency

How efficient is Ironwood Pharmaceuticals business performance
Ironwood Pharmaceuticals's return on equity has shrunk by 69% YoY and by 3.9% QoQ
Ironwood Pharmaceuticals's return on assets has shrunk by 65% YoY
Ironwood Pharmaceuticals's ROIC has increased by 12% YoY and by 6% from the previous quarter
The return on sales has increased by 12% year-on-year

Dividends

What is IRWD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for IRWD.

Financial health

How did Ironwood Pharmaceuticals financials performed over time
The total assets is 158% more than the total liabilities
IRWD's total liabilities is down by 21% year-on-year
Ironwood Pharmaceuticals's current ratio has increased by 19% from the previous quarter
IRWD's debt is 41% smaller than its equity
The company's debt to equity fell by 43% YoY and by 8% QoQ
The company's equity rose by 37% YoY and by 8% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.